Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States.
Authors: Al Rawashdh N; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Patel BV; Tandem Diabetes Care, San Diego, California, USA., Wang SM; Tandem Diabetes Care, San Diego, California, USA., Zur RM; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Anaya P; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Kahn EB; IQVIA, Real-World Evidence Solutions, Falls Church, Virginia, USA., Pinsker JE; Tandem Diabetes Care, San Diego, California, USA., Sasson-Katchalski R; Tandem Diabetes Care, San Diego, California, USA., Trahan AC; Tandem Diabetes Care, San Diego, California, USA., Messer LH; Tandem Diabetes Care, San Diego, California, USA., Assadi K; Tandem Diabetes Care, San Diego, California, USA., Kudva YC; Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Beck RW; Jaeb Center for Health Research, Tampa, Florida, USA.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 6280-6290. Date of Electronic Publication: 2026 May 05.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1463-1326
DOI:10.1111/dom.70759